Related Experiment Videos
Actions of tizanidine on alpha 1-and alpha 2-adrenoceptors in the peripheral tissues
General Pharmacology
|January 1, 1984
Abstract:
Tizanidine behaved as the partial agonist on the alpha 1-adrenoceptor in high doses (10(-6) -10(-4)M) and as the alpha 2-adrenoceptor agonist in low doses (3 X 10(-9) - 10(-6)M). Tizanidine is about one-third as potent as clonidine in alpha 2-agonistic effect
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer.
The British journal of radiology·2014
Analyses of laboratory data and establishment of reference values and intervals for healthy elderly people.
The journal of nutrition, health & aging·2012
New treatment of free-radical scavenger in adrenoleukodystrophy.
Journal of clinical pharmacy and therapeutics·2011
Prenatal diagnosis of unilateral proximal femoral focal deficiency at 19 weeks' gestation: case report and review of the literature.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Chromosome elimination in the interspecific hybrid medaka between Oryzias latipes and O. hubbsi.
Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2007
Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.
General pharmacology·2002
Investigation of basal endothelial function in the obese Zucker rat in vitro.
General pharmacology·2002
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.
Expert opinion on pharmacotherapy·2026
New potassium binders: we need them-we do not need them.
Clinical kidney journal·2026
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.
Diabetes, obesity, and cardiometabolic CARE·2026
Ibogaine for Substance Use Disorders.
Advances in therapy·2026